Cause 03 / 04 Healthcare

Healthcare

Advancing breakthroughs at the frontlines

Clinicians collaborating on patient care
Fig. 01 Clinicians collaborating on patient care. Photo credit: Dana-Farber.
¶ 01 Why it matters
There are many whose health conditions are left on the margins of treatment. We address critical gaps through technology.

We invest where urgent problems meet enduring solutions — from metastatic breast cancer care to new treatment modalities for Parkinson’s disease.

¶ 02 The work
01

Dana-Farber Breast Cancer Program

Enabling critical interventions

  • Optimize metastatic breast cancer clinical trials by identifying biomarkers that predict treatment response
  • Leverage large-scale data and artificial intelligence to predict disease recurrence and treatment response
  • Use liquid diagnostics for metastatic breast cancer to enable real-time treatment monitoring and develop interventions that prevent recurrence
  • Offer annual internal awards for innovative metastatic breast cancer research
02

Cedars-Sinai Parkinson’s Program

Coordinating patient care

  • Form and deploy a new clinical care and research team for the rollout of the Kneu Health Program
  • 300 patients experience optimized care through the Kneu Health Program rollout
  • Approximately 1,000 patients experience improved continuity of care through a new hospital dashboard
03

Baptist Health Miami Neuroscience Institute

Providing hope for Parkinson’s disease patients

  • Advance clinical research to enhance treatment outcomes and develop new therapies
  • Deploy innovative care solutions including deep brain stimulation, AI-enabled wearables, pharmacogenomic testing, and remote monitoring
  • Build multidisciplinary care models and strengthen patient navigation systems
  • Scale community outreach and education
¶ 03 How it’s unfolding
Researchers at work in a laboratory
Fig. 02

Researchers at work in a laboratory.

Field report — Healthcare

At Dana-Farber, support has built one of the world’s most comprehensive infrastructures for Stage IV breast cancer, enrolling over 4,000 patients, with an AI repository drawn from more than 20,000 patients.

At Cedars-Sinai, the Kneu Health Program is transforming Parkinson’s care through digital platforms connecting hospital and home.

¶ 04 In numbers
4,000+ patients enrolled in Stage IV breast cancer research
20,000+ patients informing an AI research repository
1,300 patients receiving optimized, coordinated Parkinson’s care